“…Lineage-specific progenitors are mostly tissue-specific stem cells that include mesenchymal stem cells (MSCs) for adipose, muscle, or bone; hematopoietic stem cells (HSCs) for blood or bone remodeling; and neural stem cells (NSCs) for the nervous system. Since ethical concerns limit the therapeutic applicability of ES cells in humans, autograft therapy using self-stem cells has been pursued to treat diverse categories of diseases including neurologic abbreviation abbreviation AR NR3C4 Adipogenesis (Singh et al, 2006;Gupta V et al, 2008) Myogenesis (Singh et al, 2003(Singh et al, , 2009) COUP-TFβ NR2F2 Adipogenesis (Xu et al, 2008;Li et al, 2009) Myogenesis (Bailey et al, 1998Lee et al, 2004) DAX-1 NR0B1 ES cell stemness (Wang et al, 2006;Kim et al, 2008;Sun et al, 2008;Xie et al, 2009) ERβ NR3A2 NSC differentiation (Wang et al, 2001;Brannvall et al, 2002;Kishi et al, 2005) ERRβ NR3B2 ES cell stemness (Zhou et al, 2007;van den Berg et al, 2008;Zhang X et al, 2008) Induce iPS cells (Gu et al, 2005a;Feng et al, 2009) GCNF NR6A1 ES cell differentiation (Gu et al, 2005b) Neuronal differentiation (Sattler et al, 2004;Chung et al, 2006;Akamatsu et al, 2009 (Wallen-Mackenzie et al, 2003;Perlmann and Wallen-Mackenzie, 2004;Blin et al, 2008;Jacobs et al, 2009) PPARδ NR1C2 Transdifferentiation (Holst et al, 2003Wang et al, 2004;Teunissen et al, 2007) PPARγ NR1C3 Adipogenesis (Tontonoz et al, 1994;Hu et al, 1995;Fu et al, 2005;Crossno et al, 2006;Yu et al, 2006;...…”